Precigen, Inc. (PGEN)
4.715
+0.24
(+5.48%)
USD |
NASDAQ |
Nov 09, 16:00
4.66
-0.06
(-1.17%)
After-Hours: 17:49
Precigen Gross Profit (Annual) : 3.588M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 3.588M |
| December 31, 2024 | -3.401M |
| December 31, 2023 | -4.742M |
| December 31, 2022 | 15.77M |
| December 31, 2021 | 3.249M |
| December 31, 2020 | 47.66M |
| December 31, 2019 | 29.32M |
| December 31, 2018 | 88.50M |
| Date | Value |
|---|---|
| December 31, 2017 | 168.19M |
| December 31, 2016 | 129.29M |
| December 31, 2015 | 109.68M |
| December 31, 2014 | 42.26M |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Anika Therapeutics, Inc. | 63.81M |
| Aldeyra Therapeutics, Inc. | -0.252M |
| Repligen Corp. | 350.64M |
| AC Immune SA | 0.00 |
| Inovio Pharmaceuticals, Inc. | -2.924M |